Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-19T08:26:19.058Z Has data issue: false hasContentIssue false
  • English
  • Français

Regulatory Issues Concerning Behavioral and Psychological Symptoms of Dementia in Japan

Published online by Cambridge University Press:  10 January 2005

Akira Homma
Akira Homma
Affiliation:
Department of Psychiatry, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Get access Rights & Permissions [Opens in a new window]

Extract

In 1996, the Japanese Ministry of Health and Welfare organized a working group to develop guidelines to assess the clinical efficacy of drugs used to treat dementia. The major issues discussed at that time included the definition of antidementia drugs, outcome measures, concomitant treatments, and placebo issues. Because the primary objective of this group was to develop guidelines for the symptomatic treatment of the disease, issues related to slowing of disease progression and behavioral and psychological symptoms of dementia (BPSD) were not discussed in detail. In 1997, the group submitted a draft report to the Japanese Ministry of Health and Welfare. It is hoped that in the future, this group will address issues not discussed in the draft guidelines.

Type
Regulatory Issues
Information
International Psychogeriatrics , Volume 12 , Issue S1 , July 2000 , pp. 327 - 329
Copyright
© 2000 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)